Company:  SYNLOGIC, INC. (SYBX)
Form Type:  8-K
Filing Date:  6/12/2019 
CIK:  0001527599 
Address:  301 BINNEY STREET
SUITE 402
 
City, State, Zip:  CAMBRIDGE, Massachusetts 02142 
Telephone:  617-401-9975 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.00  
Change: 
-0.03 (-1.48%)  
Trade Time: 
Jul 10  
Market Cap: 
$65.68M
Trade SYBX now with 

© 2020  
Description of Business
We are a clinical-stage biopharmaceutical company focused on advancing our proprietary drug discovery and development platform to create Synthetic Biotic(TM) medicines. Our Synthetic Biotic medicines apply the principles and tools of synthetic biology to engineer beneficial therapeutic characteristics into microbes, transforming them into efficient and targeted biologic engines. We believe that many patients with serious diseases are underserved today based on the limitations of conventional therapeutic approaches, such as small or large molecules. Synthetic Biotic medicines have the potential to address unmet medical need by performing therapeutic mechanisms not achievable by other drug modalities. Synthetic Biotic medicines are designed to be programmed to metabolize, or consume, a toxic substance, compensate for damaged metabolic pathways in patients, or produce one or more therapeutic factors.
Register and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01 Entry into a Material Definitive Agreement.
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.02 Unregistered Sale of Equity Securities
    SECTION 7 REGULATION FD
      Item 7.01 Regulation FD Disclosure.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits
    SIGNATURES
  EXHIBIT 4.1
  EXHIBIT 10.1
  EXHIBIT 99.1
  EXHIBIT 99.2